SCHEMBL1258488

SCHEMBL1258488

CC(C)(C)OC(=O)CNC(=S)Nc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABAT P80404 1/20 0.64
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 5/20 0.50
GAA P10253 4/20 0.50
LMNA P02545 3/20 0.50
HPGD P15428 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
EPHX1 P07099 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
XBP1 P17861 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
CYP3A4 P08684 1/20 0.47
TAS2R38 P59533 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25840843 0.87 SMN1; SMN2 (0.51) ABATKMT2AALDH1A1GAAHPGD
SCHEMBL23328386 0.83 CDK1 (0.56) ABATKMT2AALDH1A1GAALMNA
SCHEMBL4401844 0.82 KMT2A (0.56) ABATKMT2AALDH1A1GAALMNA
SCHEMBL10453740 0.82 IDO1 (0.49) ABATKMT2AALDH1A1GAALMNA
SCHEMBL10453343 0.81 ALDH1A1 (0.54) KMT2AALDH1A1LMNAL3MBTL1HTT
SCHEMBL4396662 0.80 KMT2A (0.54) ABATKMT2AALDH1A1GAALMNA
SCHEMBL4392250 0.80 KMT2A (0.54) ABATKMT2AALDH1A1GAALMNA
SCHEMBL1258720 0.79 ALDH1A1 (0.53) ABATKMT2AALDH1A1GAALMNA
SCHEMBL303932 0.79 PKM (0.46) KMT2AALDH1A1LMNAHPGDL3MBTL1
SCHEMBL11517574 0.79 ABAT (1.00) ABATKMT2AALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8252940-B2 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection UNIVERSITY OF WASHINGTON (US) 2012-08-28 US disclosed
US-20110039849-A1 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION UNIVERSITY OF WASHINGTON (US) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039849-A1 5-SUBSTITUTED-2-IMINO-THIAZOLIDINONE COMPOUNDS AND THEIR USE AS INHIBITORS OF BACTERIAL INFECTION IRF3, GDI2, TLR5 ABAT 1764/4885KMT2A 4843/4885ALDH1A1 4529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.